01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

cells by p53 protein is accompanied by hemoglobin
production and is sensitive to erythropoietin. Mol Cell Biol
13, 1456-1463.
Johnston BH (1988) The S1-sensitive form of d(C-T)n.d(A-G)n:
chemical evidence for a three-stranded structure in plasmids.
Science 241, 1800-1804.
Joki T, Nakamura M, and Ohno T (1995) Activation of the
radiosensitive EGR-1 promoter induces expression of the
herpes simplex virus thymidine kinase gene and sensitivity
of human glioma cells to ganciclovir. Hum Gene Ther 6,
1507-1513.
Jomary C, Vincent KA, Grist J, Neal MJ, Jones SE (1997)
Rescue of photoreceptor function by AAV-mediated gene
transfer in a mouse model of inherited retinal degeneration.
Gene Ther 4, 683-690.
Jones, K.A., Kadonaga, J.T., Rosenfeld, P.J., Kelly, T.J. and
Tjian, R. (1987) A cellular DNA-binding protein that
activates eukaryotic transcription and DNA replication. Cell
48, 79-89.
Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E,
Jami J, and Bucchini D (1996) Targeted disruption of the
insulin receptor gene in the mouse results in neonatal
lethality. EMBO J 15, 1542-1547.
Ju DW, Cao X, Acres B (1997) Intratumoral injection of GM-
CSF gene encoded recombinant vaccinia virus elicits potent
antitumor response in a mixture melanoma model. Cancer
Gene Ther 4, 139-144.
Junker U, Baker J, Kalfoglou CS, Veres G, Kaneshima H,
Bohnlein E (1997) Antiviral potency of drug-gene therapy
combinations against human immunodeficiency virus type 1.
AIDS Res Hum Retroviruses 13, 1395-1402.
Kaelin WG Jr, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum
F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, et
al (1992) Expression cloning of a cDNA encoding a
retinoblastoma-binding protein with E2F-like properties.
Cell 70, 351-364.
Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM (1997)
Sustained expression of genes delivered directly into liver
and muscle by lentiviral vectors. Nat Genet 17, 314-317.
Kagami H, O'Connell BC, Baum BJ (1996) Evidence for the
systemic delivery of a transgene product from salivary
glands. Hum Gene Ther 7, 2177-2184.
Kahn P (1995) From genome to proteome: Looking at a cell's
proteins. Science 270, 369-370.
Kamata H, Yagisawa H, Takahashi S, Hirata H (1994)
Amphiphilic peptides enhance the efficiency of liposomemediated
DNA transfection. Nucleic Acids Res 22, 536-537.
Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ
(1997) Acute stimulation of glucose metabolism in mice by
leptin treatment. Nature 389, 374-377
Kamps, M.P., Look, A.T. and Baltimore, D. (1991) The human
t(1;19) translocation in pre-B ALL produces multiple nuclear
E2A-Pbx1 fusion proteins with differing transforming
potentials. Genes Dev. 5, 358-368.
Kaneda Y, Iwai K, and Uchida T (1989) Increased expression of
DNA cointroduced with nuclear protein in adult rat liver.
Science 243, 375-378.
Boulikas: An overview on gene therapy
144
Kaneda Y, Morishita R, Dzau VJ (1997) Prevention of restenosis
by gene therapy. Ann N Y Acad Sci 811, 299-308.
Kaplan JM, Armentano D, Sparer TE, Wynn SG, Peterson PA,
Wadsworth SC, Couture KK, Pennington SE, St George JA,
Gooding LR, Smith AE (1997) Characterization of factors
involved in modulating persistence of transgene expression
from recombinant adenovirus in the mouse lung. Hum Gene
Ther 8, 45-56.
Karanikas V, Hwang LA, Pearson J, Ong CS, Apostolopoulos V,
Vaughan H, Xing PX, Jamieson G, Pietersz G, Tait B,
Broadbent R, Thynne G, McKenzie IFC (1997) Antibody
and T cell responses of patients with adenocarcinoma
immunized with mannan-MUC1 fusion protein. J Clin
Invest 100, 2783-2792.
Karet FE, Lifton RP (1997) Mutations contributing to human
blood pressure variation. Recent Prog Horm Res 52, 263-
276.
Karlsson S (1991) Treatment of genetic defects in hematopoietic
cell function by gene transfer. Blood 78, 2481-2492.
Kasahara N, Dozy AM, Kan YW (1994) Tissue-specific
targeting of retroviral vectors through ligand-receptor
interactions. Science 266, 1373-1376.
Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh
WV, Plunkett BS, Vogelstein B and Fornace AJ (1992) A
mammalian cell cycle checkpoint pathway utilizing p53 and
GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-
597.
Kato K, Nakanishi M, Kaneda Y, Uchida T, Okada Y (1991)
Expression of hepatitis B virus surface antigen in adult rat
liver. Co-introduction of DNA and nuclear protein by a
simplified liposome method. J Biol Chem 266, 3361-3364.
Kato T, Iwamoto K, Ando H, Asakawa N, Tanaka I, Kikuchi J,
Murakami Y (1996) Synthetic cationic amphiphile for
liposome-mediated DNA transfection with less cytotoxicity.
Biol Pharm Bull 19, 860-863.
Kawabata K, Takakura Y, Hashida M (1995) The fate of plasmid
DNA after intravenous injection in mice: involvement of
scavenger receptors in its hepatic uptake. Pharm Res 12,
825-830.
Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F,
Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR,
Read M, Brinkhous KM, Woo SLC (1994) In vivo hepatic
gene therapy: Complete albeit transient correction of factor
IX deficiency in hemophilia B dogs Proc Natl Acad Sci
USA 91, 2353-2357.
Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F,
Toman C, Finegold M, Thompson AR, Read MS, Brinkhous
KM, and Woo SLC (1993) In vivo gene therapy of
hemophilia B: Sustained partial correction in factor IXdeficient
dogs. Science 262, 117-119.
Kazazian HH Jr, Wong C, Youssoufian H, Scott AF, Phillips
DG, and Antonarakis S (1988) Haemophilia A resulting from
de novo insertion of L1 sequences represents a novel
mechanism for mutation in man. Nature 332, 164-166.
Kearns WG, Afione SA, Fulmer SB, Pang MC, Erikson D, Egan
M, Landrum MJ, Flotte TR, Cutting GR (1996) Recombinant
adeno-associated virus (AAV-CFTR) vectors do not